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ADDING TRIAMCINOLONE TO VISCOSUPPLEMENTATION: ONE YEAR
OUTCOME OF RANDOMIZED TRIAL
G.C. Campos, M.U. Rezende, R. Fruchi, T. Pasqualin, M.I. Hissadomi. IOT
– FMUSP, S~ao Paulo, Brazil
Purpose: This is an extended follow up of a randomised controlled trial
to evaluate if the addition of triamcinolone to viscosupplementation
could alter one-year pain and function of viscosupplementation alone.
Methods: We prospectively enrolled 104 patients with knee osteo-
arthritis and randomized them to receive either a single intraarticular
injection (6 mL) of hylan GF-20 (Group viscosupplementation [Group
VS]), or a single intraarticular injection of hylan GF-20 (6 mL) and 1 mL
(20mg) of triamcinolone hexacetonide (Group VSþT). VAS,WOMACTM,
and Lequesne questionnaires were completed at baseline, at weeks 1, 4,
12, 24 and at one year.
Results: At week 1 the WOMAC and VAS scores were lower in Group
VSþT, compared with Group VS. There was no difference regarding the
adverse effects. At weeks 4, 12, 24 and one year there were no differ-
ences within the groups. At one year only Group VSþT still showed a
difference from baseline for VAS.
Conclusions: The addition of triamcinolone hexacetonide improves
ﬁrst-week symptom and functional scores of viscosupplementation and
does not alter its adverse effects. There might be beneﬁts for the one
year pain results.
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LONG-TERM EFFECT OF A FLEXIBLE MINIMALIST SHOE ON ALGO-
FUNCTIONAL, ANALGESIC MEDICATION INTAKE AND GAIT
KINEMATIC IN ELDERLY WOMEN WITH KNEE OSTEOARTHRITIS
A. Matias, F. Trombini-Souza, M. Yokota, I. Pereira, C. Schainberg,
R. Fuller, I.C. Sacco. Univ. of Sao Paulo, Sao Paulo, Brazil
Purpose: To evaluate the therapeutic effect of a minimalist and inex-
pensive footwear on pain, function, gait kinematics and paracetamol
intake in elderly women with knee OA.
Methods: A randomized, parallel and controlled clinical trial, with blind
assessor was carried out. Fifty-six elderly women with knee OA graded
2 or 3 (Kellgren and Lawrence) were randomly allocated into the
intervention group (IG, n ¼ 28) or the control group (CG, n ¼ 28) and
assessed at baseline (T0), after three (T3) and after six months of
intervention (T6). The IG patients should wear the minimalist shoes
(Moleca) for at least 6-hours daily. Moleca shoe (Calçados Beira Rio
S.A., Novo Hamburgo, RS, Brazil) is awomen’s double canvas ﬂexible ﬂat
walking shoe without heels, with a 5-mm anti-slip rubber sole. The CG
could not wear these shoes or any other similar, as well as be under
physical therapy or acupuncture treatment for the knee OA throughout
these 6-months. Paracetamol intake (500 milligrams) for every 6 hour
was allowed for both groups only in extreme pain situation. The out-
comes of the study were: Lequesne algo-functional score, paracetamol
intake, and lower limb kinematics while walking. The time effects (T0,
T3 and T6), group (IG and CG) and interaction (time vs. group) were
tested by two-way casewise ANOVA.
Results: The IG wore the Moleca shoe for an average monthly of 7h40
a day, achieving improvement of 35% in Lequesne algo-functional score
at T3 (p< 0.001; large within-group effect size: 1.07) and 43% at T6 (p<
0.001; large within-group effect size: 1.31). In CG, there was an
improvement of 23% at T3 (p < 0.001; moderate within-group effect
size: 0.71) and 16% at T6 (p < 0.001; moderate within-group effect size:
0.45). From T3 to T6, the CG got worse in the Lequesne algo-functional
score in 8.9%, while the IG showed an improvement throughout the 6-
months. The CG signiﬁcantly increased the rescue medication intake
throughout the trial, which possibly resulted in their algo-functional
improvement. The IG, on the other hand, showed just a slightly increase
in the paracetamol intake at the end of the 1st, 2nd and 3rd months.
However, at 4th, 5th and 6th months, the paracetamol intake was again
similar to the baseline status. From the 2nd to 6th month, this practice
was signiﬁcantly higher in CG compared to IG. Although the IG patients
have achieved a higher improvement in algo-functional aspect of the
disease, and a reduction in rescue medication intake, there was no
interaction effect for: knee early ﬂexion (p¼ 0.293), knee ﬁnal ﬂexion (p
¼ 0.742), knee extension (p¼ 0.337), and sagittal range of the knee (p¼
0.417).
Conclusion: The results suggests that the usage of Moleca shoe can be
considered as a conservative treatment of knee OA to improve the algo-functional aspects and to reduce the analgesic medication intake,
keeping unchanged the kinematics of the knee during gait.
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FORCE PLATFORM ANALYSIS OF THE EFFECT OF INTRARTICULAR
INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED MESENCHYMAL
STEM CELLS ASSOCIATED TO PRGF IN OSTEOARTHRITIC DOGS
M. Rubio Zaragoza y,z, B. Cuervo Serrato y,z, J.M. Carrillo Poveda y,z,
J.J. Sopena Juncosa y,z, R. Cugat Bertomeu x,z, M. Garcia Balletbo x,z,
M. Morales Fari~na k, J.M. Vilar Guere~no k. yUniv. CEU Cardenal Herrera,
Alfara del Patirarca, Spain; zGarcia Cugat Fndn. CEU-UCH Chair of Med.
and Regenerative Surgery, Valencia, Spain; xArtroscopia GC, Barcelona,
Spain; kUniv. Las Palmas de Gran Canaria, Las Palmas de Gran Canaria,
Spain
Purpose: Adipose-derived mesenchymal stem cell (aMSC) therapy
in regenerative medicine is a rapidly growing area of research and
is currently also being used to treat osteoarthritis (OA). Force
platform analysis has been consistently used to verify the efﬁcacy
of different therapeutic strategies for the treatment of OA in dogs,
but never with aMSC. Recent investigations have shown that
growth factors contained in platelet-rich plasma (PRGF) act as
vehicles and even potentiators of the effect of aMSCs. The purpose
of this study was to use force platform kinetic analysis to evaluate
the effect of a single intraarticular injection of aMSC in 8 dogs with
OA of hip joints by measuring peak vertical force (PVF) and vertical
impulse (VI), which represent maximal weight bearing and dis-
tribution of forces through time, respectively.
Methods: Eight adult client-owned Canarian Presa dogs (5 males, 3
females) with OA were inﬁltrated with aMSC and PRGF. Dog owners
were informed and granted a signed consent for the whole proce-
dure. Stem cell extraction and inoculation phases were performed
under general anesthesia (sevoﬂurane). The adipose tissue (inguinal
region) was processed using the Dog Stem (Fat-Stem) protocol. The
number of mesenchymal stem cells was over 30 million, certiﬁed
with a laboratory certiﬁcate for the quality of the cells and received
in two 2 ml tubes with 15 million per tube. Once the aMSC were
received they were inﬁltrated with the PRGF-Endoret that was
prepared in that moment (centrifuged during 8 minutes at 460 G
and activated with 5% of its volume with 10% calcium chloride). The
resultant 4 ml solution was injected aseptically into the hip joints
through conventional artrocenthesis sites. Gait analysis was per-
formed using a single platform mounted in the center of, and level
with, a 7-m runway covered by a rubber mat. The mat weight was
discarded setting to “0 force” with the tare button after the platform
was covered. Dogs were leash guided at walk over the force plat-
form by the same handler. Walk velocity was measured by use of a
motion sensor (Pasco, California, USA) positioned 1 m apart from the
platform. Five valid trials, at a sampling frequency of 250 Hz, were
obtained for each dog. A member of the research team evaluated the
trial to conﬁrm which limb touched the center of the force platform.
The platform was interfaced with a dedicated computer using
DataStudio. Data were recorded from both affected limbs at day 0,
30, 90, and 180 post-treatment; the obtained PVF and VI values were
normalized relative to body weight (%) to characterize the possible
improvement of lameness during treatment with aMSCs. Data were
analyzed with a linear mixed effects model for a blocked design with
repeated measures. The time and the lame-sound of the dog were
considered as ﬁxed effects factors, while the dog was a random
effects factor. Signiﬁcance of the differences in PVF and VI between
periods of observation was tested by means of analysis of variance of
these models, with a post-hoc Tukey’s test. For assessing the rela-
tionships between supporting force in the more-lame and the less-
lame limbs and also between vertical impulses in the two limbs, a
regression model with random effects of dog on slope and intercept
was used. Signiﬁcance level was set at P  0.05 in all tests.
Results: Eight lame dogs with severe hip OA and a control group of 5
sound dogs were used for this study. Results were statistically analyzed
to detect a signiﬁcant increase in peak vertical force (PVF) and vertical
impulse (VI) in treated dogs. Mean values of PVF and VI were sig-
niﬁcantly improved after treatment of the OA groups, reaching 53.02%
and 14.84% of bodyweight, respectively, at day 180, comparedwith only
43.56% and 12.16% at day 0.
Conclusions: This study objectively demonstrated that intraarticular
aMSC therapy resulted in reduced lameness due to OA.
